Skip to content
GenoLensGenoLens

TCF20

Chr 22q13.2

transcription factor 20

Aliases:
AR1, SPBP
MANE:
ENST00000677622.1

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • developmental delay with variable intellectual impairment and behavioral abnormalities

    0.80
  • Intellectual disability

    0.56
  • Neurodevelopmental abnormality

    0.54
  • hereditary disease

    0.53
  • Developmental delay with variable intellectual impairment and behavioural abnormalities

    0.51
  • Neurodevelopmental delay

    0.46
  • Global developmental delay

    0.46
  • autism

    0.43
  • Mild intellectual disability

    0.43
  • Generalized hypotonia

    0.42

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Transcription factor 20

Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.